BMS Expands its Existing Patient Support Programs to Aid Uninsured Patients in the US Amid COVID-19

 BMS Expands its Existing Patient Support Programs to Aid Uninsured Patients in the US Amid COVID-19

BMS Reports Results of Triple Regimen in P-III ELOQUENT-1 Study for Patients with Newly Diagnosed Untreated Multiple Myeloma

Shots:

  • The expanded program offers access to any branded BMS’s therapies for free, including its most widely prescribed therapies and those prescribed via telehealth services
  • Patients can reach to BMS’ patient support programs by calling it on (800) 721-8909 or by visiting BMS.com.
  • The program provides immediate access for patients who have lost their employment and health insurance, includes a single point of entry, streamlined enrollment process and a voucher to assist with continuity of care for self-administered BMS therapies

Click here ­to­ read full press release/ article | Ref: BMS | Image: BMS

Tuba Khan

Tuba Khan is Senior Editor at PharmaShots. She is curious, creative, and passionate about recent updates and innovation in the Life sciences industry. She covers Biopharma, MedTech, and Digital health segments. Tuba also has an experience of digital and social media marketing and runs the campaigns independently. She can be contacted on tuba@pharmashots.com

Related post